Prevalence and Characteristics of Painful Diabetic Neuropathy in a Large Community-Based Diabetic Population in the U.K.
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess, in the general diabetic population, 1) the prevalence of painful neuropathic symptoms; 2) the relationship between symptoms and clinical severity of neuropathy; and 3) the role of diabetes type, sex, and ethnicity in painful neuropathy. RESEARCH DESIGN AND METHODS: Observational study of a large cohort of diabetic patients receiving community-based health care in northwest England (n = 15,692). Painful diabetic neuropathy (PDN) was assessed using neuropathy symptom score (NSS) and neuropathy disability score (NDS). RESULTS: Prevalence of painful symptoms (NSS ≥5) and PDN (NSS ≥5 and NDS ≥3) was 34 and 21%, respectively. Painful symptoms occurred in 26% of patients without neuropathy (NDS ≤2) and 60% of patients with severe neuropathy (NDS >8). Adjusted risk of painful neuropathic symptoms in type 2 diabetes was double that of type 1 diabetes (odds ratio [OR] = 2.1 [95% CI 1.7–2.4], P < 0.001) and not affected by severity of neuropathy, insulin use, foot deformities, smoking, or alcohol. Women had 50% increased adjusted risk of painful symptoms compared with men (OR = 1.5 [1.4–1.6], P < 0.0001). Despite less neuropathy in South Asians (14%) than Europeans (22%) and African Caribbeans (21%) (P < 0.0001), painful symptoms were greater in South Asians (38 vs. 34 vs. 32%, P < 0.0001). South Asians without neuropathy maintained a 50% increased risk of painful neuropathy symptoms compared with other ethnic groups (P < 0.0001). CONCLUSIONS: One-third of all community-based diabetic patients have painful neuropathy symptoms, regardless of their neuropathic deficit. PDN was more prevalent in patients with type 2 diabetes, women, and people of South Asian origin. This highlights a significant morbidity due to painful neuropathy and identifies key groups who warrant screening for PDN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Diabetic peripheral polyneuropathy (also known as diabetic neuropathy) affects 50% of patients with diabetes [3–5]”
From A Consideration of the Psychological Aspects to Managing Patients with Painful Diabetic Neuropathy: An Insight into Pain Management Services at a Tertiary Centre in the UK (2021) · cites this paper as [4]
Experimental — accuracy not yet measuredIn the citing paper
“with previous studies suggesting that it affects 21% of patients with neuropathy (23)”
From Development of a Core Outcome Set for Studies Assessing Interventions for Diabetes-Related Foot Ulceration (2024) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The global burden of diabetic foot disease
Boulton, A. J., Vileikyte, L., Ragnarson-Tennvall, G., & Apelqvist, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67698-2 · Cited by 2,566
Self-citationYoung, M. J., Boulton, A. J. M., Macleod, A. F., Williams, D. R. R., & Sonksen, P. H. (1993) · Diabetologia · doi:10.1007/bf00400697 · Cited by 1,502
Self-citationAbbott, C. A., Carrington, A. L., Ashe, H., Bath, S., Every, L. C., Griffiths, J., Hann, A. W., Hussein, A., Jackson, N., Johnson, K. E., et al. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00698.x · Cited by 1,056
Self-citationThe Prevalence, Severity, and Impact of Painful Diabetic Peripheral Neuropathy in Type 2 Diabetes
Davies, M., Brophy, S., Williams, R., & Taylor, A. (2006) · Diabetes Care · doi:10.2337/dc05-2228 · Cited by 746
Tesfaye, S., Stevens, L. K., Stephenson, J. M., Fuller, J. H., Plater, M., Ionescu-Tirgoviste, C., Nuber, A., Pozza, G., & Ward, J. D. (1996) · Diabetologia · doi:10.1007/s001250050586 · Cited by 695
Bril, V., England, J., Franklin, G. M., Backonja, M., Cohen, J., Del Toro, D., Feldman, E., Iverson, D. J., Perkins, B., Russell, J. W., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e3182166ebe · Cited by 634
Daousi, C., MacFarlane, I. A., Woodward, A., Nurmikko, T. J., Bundred, P. E., & Benbow, S. J. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01271.x · Cited by 454
Foot complications in Type 2 diabetes: an Australian population‐based study
Tapp, R. J., Shaw, J. E., De Courten, M. P., Dunstan, D. W., Welborn, T. A., & Zimmet, P. Z. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00881.x · Cited by 193
Cabezas-Cerrato, J. (1998) · Diabetologia · doi:10.1007/s001250051063 · Cited by 192
Abbott, C. A., Garrow, A. P., Carrington, A. L., Morris, J., Van Ross, E. R., & Boulton, A. J. (2005) · Diabetes Care · doi:10.2337/diacare.28.8.1869 · Cited by 171
Self-citation
Cited by
Items 801–870 of 870
Rafique, N., Rafique, A., Bilal, H. B., Nawaz, I., & Ali, M. (2023) · Journal of Medical Sciences · doi:10.52764/jms.23.31.2.9 · Cited by 2
Analysis of medications for symptomatic treatment of the painful diabetic polyneuropathy in Ukraine
Власенко, І. О., Mankovsky, B., & Monashnenko, O. O. (2023) · Fìtoterapìâ · doi:10.32782/2522-9680-2023-1-71
Diabetic Sensory Neuropathy and Plantar Pressure Changes
Khalel, M. S., kandil, I., & Motawea, M. M. (2023) · Benha Medical Journal · doi:10.21608/bmfj.2023.167785.1684
Márton, L., & Szabó, M. I. (2023) · Acta Marisiensis. Seria Medica · doi:10.2478/amma-2023-0023
Is Cerebrolysin effective in reducing symptoms of Diabetic Peripheral Neuropathy?
(2023) · Journal of Endocrinology and Diabetes · doi:10.15226/2374-6890/10/1/001159
Sari, T. P., Perwitasari, D. A., & Supadmi, W. (2023) · Jurnal Riset Kefarmasian Indonesia · doi:10.33759/jrki.v5i3.390
Nyirenda, C. K., Namfukwe, T., Maliko, C. N., Chinkoyo, S., Zulu, M., Maksoud, G., & Chimese, M. (2023) · British journal of healthcare and medical research · doi:10.14738/bjhmr.106.15943
Rajurkar, R. D., Harjpal, P. L., & Tikhile, P. (2024) · Cureus · doi:10.7759/cureus.52056
“Diabetic neuropathy leads to severe illness and a decline in sensory function that initiates in the lower limbs and is accompanied by discomfort [12].”
BackgroundAzmi, S., Alam, U., & Malik, R. A. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch45 · Cited by 1
Self-citationMicrovascular complications: Diabetic nerve disease
Malik, R. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-22106-4.00016-4
Self-citationAn Investigation On Novel Combination For Diabetic Neuropathy
Jalindar, M. V. S., & Kulkarni, A. D. (2024) · Journal Of Advanced Zoology · doi:10.53555/jaz.v45i2.3904
MANAJEMEN NYERI POST OPERASI AMPUTASI PADA PASIEN DIABETES MELITUS TIPE II
Betten, I. C., Sanan, Y. C. U., Rohi, E. D. F. R., & Berek, P. A. L. (2024) · Jurnal Sahabat Keperawatan · doi:10.32938/jsk.v6i01.6436 · Cited by 1
Lozeron, P. (2024) · EMC - Neurologia · doi:10.1016/s1634-7072(24)48980-0
Raghuveer, R., Hullumani, S., & Qureshi, M. I. (2024) · F1000Research · doi:10.12688/f1000research.144809.1
Cho, M., & Kim, M. Y. (2024) · Journal of Korean Biological Nursing Science · doi:10.7586/jkbns.24.012 · Cited by 1
Comparison of efficacy of carbamazepine and duloxetiene for the treatment of diabetic neuropathy.
Tariq, A., Aslam, M. A., Ishtiaque, A., Azeem, G. M., Tariq, N., Shahid, F., & Ahsan, M. (2024) · The Professional Medical Journal · doi:10.29309/tpmj/2024.31.06.7964 · Cited by 1
Guruvu, N. R., Patil, B., Marri, D., Kutikuppala, L. V. S., Devika, T., & Rao, K. S. (2024) · Apollo Medicine · doi:10.1177/09760016241258590
“[2] Crucially, inflammatory pain – which arises, for instance, in rheumatoid arthritis, where inflammation is the primary cause with altered chemical events at the site of inflammation – is mechanistically distinct from neuropathic pain and is treated and diagnosed differently.”
Zhantleuova, A., Karimova, A., & Davletov, B. A. (2024) · Bulletin of the Karaganda University “Biology medicine geography Series” · doi:10.31489/2024bmg2/127-132
Tiwana, H., & Cohen, J. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95702-1.00279-7
A multimodal approach to the treatment of painful diabetic neuropathy. Case report
Mandra, E. V., & Kim, A. (2024) · Consilium Medicum · doi:10.26442/20751753.2024.11.202819
(2000) · Time to knit · doi:10.1016/s0246-0378(23)47134-5
Araujo, V. M. D. L., Roxo, P. L. B. T., Mesquita, D. C. P., et al. (2025) · Caderno Pedagógico · doi:10.54033/cadpedv22n2-019
Henney, A. E., Frank, B., Riley, D. R. J., Anson, M., Burgess, J., Hernández, G., Lip, G. Y. H., Malik, R. A., Tesfaye, S. H., Cuthbertson, D. J., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5114592
Self-citationSinclair, A. J., Abdelhafiz, A. H., Summerbell, A. M., Cukierman‐Yaffe, T., Wylie, S., Muzulu, S., Keegan, G., Mahmoud, S., Athavale, N. V., Emmerton, D., et al. (2025) · Wiley eBooks · doi:10.1002/9781394205066.ch16
Clinical States of Pain (Taxonomy)
Hooten, W. M., D'Souza, R. S., & Nelson, A. M. (2025) · Springer eBooks · doi:10.1007/978-3-031-88357-6_3 · Cited by 1
Kim, Y., Chee, C. G., Kang, Y., et al. (2025) · Skeletal Radiology · doi:10.1007/s00256-025-04979-2
“Diabetic neuropathy is a common complication of DM, causing pain in up to 34% of patients with diabetes [2].”
Sztanek, F., Pető, A., Tóth, L. I., Lőrincz, H., Molnár, Á., Lukács, M., Menyhárt, A., Kempler, P., Paragh, G., Harangi, M., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14165780 · Cited by 1
“Objective assessments, including vibration perception threshold testing, nerve conduction studies, and standardized symptom questionnaires, remain fundamental components of the clinical evaluation of DSPN [17,18].”
Mettifogo, C. B. G., Silva, A. C. B. E., Ribeiro, A. X., et al. (2025) · Caderno Pedagógico · doi:10.54033/cadpedv22n10-263
Davalos, L., Pasnoor, M., Dimachkie, M. M., & Barohn, R. J. (2025) · Neurologic Clinics · doi:10.1016/j.ncl.2025.05.006
Fernando, K., Bell, H., Davies, S., Holmes, P., Kelly, B., & Seidu, S. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01797-6 · Cited by 1
Dhouibi, J., Migaou, H., Chaabeni, A., Kalai, A., Salah, S., Boudokhane, S., Frih, Z. B. S., & Jellad, A. (2025) · Cureus · doi:10.7759/cureus.94960 · Cited by 3
Potassium channel dysfunction and distinct sensory axonal profiles in painful type 2 diabetes
Lin, C. S.-Y., Tani, J., Hsu, T.-W., Lin, Y.-C., Liu, Y., & Sung, J.-Y. (2025) · Clinical Neurophysiology · doi:10.1016/j.clinph.2025.2111450
Liao, Q., Yang, Y., Li, Y., Zhang, J., Fan, K., Guo, Y., Chen, J., Chen, Y., Zhu, P., Huang, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26340141
Liao, Q., Yang, Y., Li, Y., Zhang, J., Fan, K., Guo, Y., Chen, J., Chen, Y., Zhu, P., Huang, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26751619
de Azevedo Vieira, A. R. S., Porto, L. B., do Prado Romani, F. A., Carvalho, P. S., Pop-Busui, R., & Pedrosa, H. C. (2024) · Figshare · doi:10.6084/m9.figshare.26584908
Liao, Q., Yang, Y., Li, Y., Zhang, J., Fan, K., Guo, Y., Chen, J., Chen, Y., Zhu, P., Huang, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26339918
Liao, Q., Yang, Y., Li, Y., Zhang, J., Fan, K., Guo, Y., Chen, J., Chen, Y., Zhu, P., Huang, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26751616
Li, M., Yao, L., Huang, H., Zhang, L., Zheng, H., Wang, G., Zhong, Z., Ma, S., Yu, S., & Wang, H. (2021) · Figshare · doi:10.6084/m9.figshare.17007086
Diabetic foot pain: expert tips on how to cope
Kamerman, P. R., & Themistocleous, A. C. (2025) · doi:10.64628/aaj.x9ch9rtu4
Neurodegenerative Disorders: Involvement of the Locus Coeruleus in the Modulation of Diabetic Pain
Núñez, A. G., Mesa-Lombardo, A., García‐Magro, N., & Martín, Y. B. (2025) · Springer eBooks · doi:10.1007/978-3-031-95878-6_10
Neurologic Complications of Endocrine Disorders
Mustafa, R. (2026) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/cont.0000000000001658 · Cited by 1
Metabolic disorders: Sex and gender evidence in dyslipidemia, diabetes, and obesity
Newman, C. B., Saunders, K. H., Schmitz, S. H., & Subramanian, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-26712-3.00020-3
Trained Immunity: Underlying Mechanistic Links between Diabetes and Periodontitis
张, 丹. (2026) · Hans Journal of Biomedicine · doi:10.12677/hjbm.2026.162029
Haridass, S., Jeyaraman, R. K., Kamarthy, P., & Kannala, P. (2026) · Journal of Health and Allied Sciences NU · doi:10.25259/jhasnu_138_2025
Influence du genre sur la prise en charge des patients diabétiques âgés en soins primaires
Al‐Salameh, A. (2018) · theses.fr (ABES) · doi:10.70675/217d4ac1z2675z4cfaz8123z5c7f1162be47
Draman, N., Abdullah, C. N. A. C., Mohamad, N., Yudin, Z. M., Ahmad, W. M. A. W., Rosli, R. R. M., & Chee, Y. C. (2026) · Current Diabetes Reviews · doi:10.2174/0115733998451787260317083008
Nie, X., Yan, J., Song, X., et al. (2026) · Scientific Data · doi:10.1038/s41597-026-07292-2
“Diabetes has become a global health crisis 1 , with more than half of patients developing neuropathy and up to one-third progressing to painful diabetic neuropathy (PDN) 2 .”
Jo, H., Kim, H.-J., Park, K.-T., Kim, H., Lee, I., & Kim, W. (2026) · Integrative Medicine Research · doi:10.1016/j.imr.2026.101350
Nerve Under Siege: Managing Diabetic Neuropathy and Pain
Alom, S., Ali, F., Abubakar, M., Yogi, S., & Bhat, H. R. (2026) · Springer eBooks · doi:10.1007/978-981-95-8946-3_3
Mousa, A. M., Mohamed, Y. A., Elzayat, S., et al. (2026) · The Egyptian Journal of Otolaryngology · doi:10.1186/s43163-026-01113-4
“In contrast, oral hypoglycemic drugs are more common in patients without neuropathy, often reflecting earlier stages of T2DM [25].”
Chu, Y., Song, H., Deng, M., Fang, Y., Ding, R., Huang, K., Fan, X., Peng, L., Yang, Y., Wei, H., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03893-1
“More than 50% of diabetic individuals get diabetic neuropathy as their condition worsens, and between 30 and 50% of them develop neuropathic pain [1, 2].”
AlRuwaili, R., Alruwaili, R. N. A., AlShammari, A. O. K., Alanzi, N. K. M., Alruwaili, Y. R., Alenzi, M. H., Alenezi, B. A. H., Alfehaid, K. F., Alsel, B. T. A., Esmaeel, S. E., et al. (2026) · Orthopedic Reviews · doi:10.52965/001c.161807
Efficacy and Safety of Ion Channel Modulators in Painful Diabetic Neuropathy
Li, D., Ouyang, L., Chen, Z., Long, Y., & Deng, G. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71053
Yang, L., Deng, R., & Chen, L. (2026) · Medicine · doi:10.1097/md.0000000000049467
Attal, N., & Spagna, A. (2025) · Dunod eBooks · doi:10.3917/dunod.poisb.2025.01.2008
Mechanisms, translational opportunities for diabetic polyneuropathy
Ong, H., Hong, M., & Zochodne, D. W. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1899469
“A study of European, Asian, and African populations suggested that 34% of diabetic patients had painful neuropathic symptoms, while 24% were diagnosed with painful diabetic neuropathy (113).”
Understanding Diabetic Neuropathy: From Pathophysiology to Therapeutic Targets
Eid, S., Rumora, A. E., Koubek, E. J., & Feldman, E. L. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-11985-9.00021-4
Alshaikh, A., Alattar, A., Hassoun, A. A. K., Alshammary, A., ElBadawi, H., Aldossari, K. K., Busaidi, N. A., Alsifri, S. N., Muzaffar, T. H., Hussein, W. I., et al. (2026) · Journal of Diabetes Investigation · doi:10.1111/jdi.70411
“27 Our recent studies from the GCC reveal a DPN prevalence of 33.3%, with speci fi c country-level prevalence of 23.9% in Qatar, 35.9% in KSA, and 40.3% in Kuwait, of whom 52.2% had advanced neuropathy and were at risk of DFU, but 53.6% were undiagnosed.”
InfluentialSelf-citationSingh, B. R., Yadav, J. P., Dwivedi, A. R., Singh, A. K., Kumar, V., Khalilullah, H., Pathak, P., & Verma, A. (2026) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-026-00646-6
Traitements médicamenteux de la neuropathie diabétique douloureuse
Laroche, S., & Phan, F. (2026) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2026.08.001
Stimulation médullaire pour le traitement de la neuropathie diabétique douloureuse
Senova, Y. S., & Lefaucheur, J. (2026) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2026.07.010
Animal Models for Neuropathic Pain Research in Type 1 and Type 2 Diabetes
Eid, S., Koubek, E. J., & Feldman, E. L. (2026) · Neuromethods · doi:10.1007/978-1-0716-5312-8_4
Correlation between Diabetes Mellitus Type 2 and Patient Tolerance to Office-based Laryngeal Surgery
Hamdan, A., Hosri, J., Feghali, P. A. R., Ghadieh, J., Lababidi, G. H., Khalil, L., Sarkis, V., Semaan, Z. M., Jalkh, R. M., & Ghzayel, L. (2026) · Journal of Voice · doi:10.1016/j.jvoice.2026.08.030
Preservation of Nociceptor Intraepidermal Nerve Fibres in Diabetic Neuropathic Pain
Lione, L. A., Hardowar, L. D., Lanigan, M. T., Bates, J., Whines, W. T. B., Jones, H., & Hulse, R. P. (2026) · Journal of Diabetes Research · doi:10.1155/jdr/4561974
Prevalence of Diabetic Neuropathy Pain: A Cross-Sectional Study among Individuals with Diabetes
Varathan, K., Kumaresan, A., Vishnuram, S., Subramanian, S. S., Siluvai, C. A., Subramanian, B., Eswaramoorthi, V., & Arjunan, P. (2026) · International journal of Nutrition Pharmacology Neurological Diseases · doi:10.4103/ijnpnd.ijnpnd_29_26
Lumbar Sympathectomy with RFA and Chemical Neurolysis for Diabetic Ischemic Limb Pain
Ahmed, S., Sardar, K., & Shaheen, M. S. A. (2026) · Indian Journal of Pain · doi:10.4103/ijpn.ijpn_68_25
Electroneurographic profiles of peripheral neuropathy in diabetic patients in Lubumbashi
Mande, J.-P. N., Mbuyamba, E. B., Obadia, P. M., Nkulu, D. N., Lubaba, C. B., Mukalay, A., Lelubre, C., Ris, L., & E‐Andjafono, D. O. L. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1928343
“Its prevalence varies depending on the diagnostic criteria and tools used; based on clinical examination alone, estimates range from 30 to 66% (13, 15).”
Metadata
- Authors
- Abbott, C. A., Malik, R. A., van Ross, E. R. E., Kulkarni, J., & Boulton, A. J. M.
- Affiliations
- University of Manchester (GB)
- Disablement Services Centre, Withington Hospital, Manchester, U.K.
- Withington Community Hospital (GB)
- Corresponding author
- Abbott, Caroline A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-09-15
- Volume
- 34
- Issue
- 10
- Pages
- 2220-2224
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3177727
- OpenAlex
- W2162902338
- Semantic Scholar
- f503e4898de5486de267534e888652f729e9319c
- Cited by
- 868
- References
- 19
- Citations by year
- 2026: 38 · 2025: 67 · 2024: 74 · 2023: 69 · 2022: 70 · 2021: 97 · 2020: 99 · 2019: 64 · 2018: 54 · 2017: 48 · 2016: 47 · 2015: 52 · 2014: 41 · 2013: 35 · 2012: 12
- FWCI
- 19.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- e-space (Manchester Metropolitan University) (acceptedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- American Diabetes Association
- National Institute for Health and Care Research
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
- Keywords
- diabetic neuropathic pain, prevalence, type 2 diabetes, type 1 diabetes, sex differences, ethnicity, South Asians, neuropathy severity, neuropathic pain, neuropathy screening
- MeSH terms
- Administration, Oral, Adult, Aged, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Neuropathies, Female, United Kingdom, Humans, Hypoglycemic Agents, Male, Middle Aged, Sex Factors, Age Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
